TREATMENT OF OSTEOARTHROTIS OF THE KNEE : SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/ne325a76Keywords:
osteoarthritis, treatmentAbstract
Background: Osteoarthritis (OA) of the knee, also referred to as degenerative joint disease of the knee, is usually caused by gradual articular cartilage loss as well as wear and tear. Seniors are more likely to experience it.
Aims : This systematic review is to review the effect and efficacy of the therapy of knee osteoarthritis.
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020, this study was able to show that it met all of the requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2014 and 2024 were taken into account. Several different online reference sources, like Pubmed, ScienceDirect and SagePub, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: In the PubMed database, the results of our search brought up 36.803 articles, whereas the results of our search on SAGEPUB brought up 10.021 articles, our search on SCIENCE DIRECT brought up 51.811 articles. The results of the search conducted for the last year of 2014 yielded a total 22.949 articles for PubMed, 6.322 articles for SAGEPUB and 28.399 articles for SCIENCE DIRECT. In the end, we compiled a total of 8 papers, 2 of which came from PubMed, 2 of which came from SAGEPUB and 4 of which came from SCIENCE DIRECT. We included eight research that met the criteria.
Conclusion: In summary, although we discovered that several treatments worked, we were unable to rate the effects since the network as a whole lacked coherence and strong confidence in the treatment comparisons.
References
Lundgren-Nilsson Å, Dencker A, Palstam A, Person G, Horton MC, Escorpizo R, et al. Patient-reported outcome measures in osteoarthritis: A systematic search and review of their use and psychometric properties. RMD Open. 2018 Dec 1;4(2).
Murphy LB, Helmick CG, Schwartz TA, Renner JB, Tudor G, Koch GG, et al. One in four people may develop symptomatic hip osteoarthritis in his or her lifetime. Osteoarthritis Cartilage. 2010 Nov;18(11):1372–9.
Elsiwy Y, Jovanovic I, Doma K, Hazratwala K, Letson H. Risk factors associated with cardiac complication after total joint arthroplasty of the hip and knee: A systematic review. Vol. 14, Journal of Orthopaedic Surgery and Research. BioMed Central Ltd.; 2019.
Springer BD. Management of the Bariatric Patient. What Are the Implications of Obesity and Total Joint Arthroplasty: The Orthopedic Surgeon’s Perspective J Arthroplasty. 2019;34(7):30–2.
Manlapaz DG, Sole G, Jayakaran P, Chapple CM. Risk Factors for Falls in Adults with Knee Osteoarthritis: A Systematic Review. PM R. 2019;11(7):745–57.
Hulshof CTJ, Colosio C, Daams JG, Ivanov ID, Prakash KC, Kuijer PPFM, et al. WHO/ILO work-related burden of disease and injury: Protocol for systematic reviews of exposure to occupational ergonomic risk factors and of the effect of exposure to occupational ergonomic risk factors on osteoarthritis of hip or knee and selected other musculoskeletal diseases. Environ Int. 2019 Apr 1;125:554–66.
Martel-Pelletier J, Maheu E, Pelletier JP, Alekseeva L, Mkinsi O, Branco J, et al. A new decision tree for diagnosis of osteoarthritis in primary care: international consensus of experts. Aging Clin Exp Res. 2019 Jan 25;31(1):19–30.
Atalay SG, Durmus A, Gezginaslan O. The Effect of Acupuncture and Physiotherapy on Patients with Knee Osteoarthritis: A Randomized Controlled Study. Pain Physician. 2021;24(3):269–78.
Bennell KL, Paterson KL, Metcalf BR, Duong V, Eyles J, Kasza J, et al. Effect of Intra-Articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients with Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA - Journal of the American Medical Association. 2021 Nov 30;326(20):2021–30.
Branch EA, Cook JJ, Cohen A, Plummer H, Emami A, Truett J, et al. Platelet-rich plasma is similar to platelet-rich plasma plus hyaluronic acid for the treatment of knee osteoarthritis at 2 years: a randomized controlled trial. Journal of Cartilage and Joint Preservation. 2023 Dec 1;3(4).
Vallejo R, Benyamin R, Orduña-Valls J, Vallejo A, Thomas SM, Cedeño DL. A randomized controlled study of the long-term efficacy of cooled and monopolar radiofrequency ablation for the treatment of chronic pain related to knee osteoarthritis. Interventional Pain Medicine. 2023 Jun;2(2):100249.
Gomoll AH, Mandelbaum BR, Farr J, Archambault WT, Sherman SL, Tabet SK, et al. An Initial Injection and a Crossover Injection of Amniotic Suspension Allograft Following Failed Treatment with Hyaluronic Acid or Saline Are Equally Effective in the Treatment of Moderate Symptomatic Knee Osteoarthritis Over 12 Months. Arthroscopy - Journal of Arthroscopic and Related Surgery. 2023 Jan 1;39(1):66–78.
Gobbi A, Morales M, Avio G, D’Ambrosi R. Double-blinded prospective randomized clinical trial in knee joint osteoarthritis treatment: safety assessment and performance of trehalose hyaluronic acid versus standard infiltrative therapy based on medium-weight sodium hyaluronate. Journal of Cartilage and Joint Preservation. 2022 Sep 1;2(3).
Cai G, Laslett LL, Aitken D, Cicuttini F, March L, Hill C, et al. Zoledronic acid plus methylprednisolone versus zoledronic acid or placebo in symptomatic knee osteoarthritis: a randomized controlled trial. Ther Adv Musculoskelet Dis. 2019;
Eftekharsadat B, Babaei-Ghazani A, Habibzadeh A, Kolahi B. Efficacy of action potential simulation and interferential therapy in the rehabilitation of patients with knee osteoarthritis. Therapeutic Advances in Muskuloskeletal Disease Sagepub. 2015;
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Journal of Advanced Research in Medical and Health Science (ISSN 2208-2425)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
